| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 22 |
| 1 | TACROLIMUS | 10 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 10 |
| 3 | TACROLIMUS OINTMENT 0.1% | 10 |
| 4 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 9 |
| 5 | MYCOPHENOLATE MOFETIL | 9 |
| 6 | ASPIRIN | 6 |
| 7 | ASPIRIN 325 MG | 5 |
| 8 | ASPIRIN 81 MG | 5 |
| 9 | CALCIUM | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | 1 | 0.0012 |
| 1 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 9 | 0.0011 |
| 2 | ELIGLUSTAT | 1 | 0.0006 |
| 3 | BRODALUMAB | 1 | 0.0005 |
| 4 | TELMISARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| 5 | DEFLAZACORT | 1 | 0.0004 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 7 | SENNOSIDES AND DOCUSATE SODIUM | 1 | 0.0003 |
| 8 | CLINDAMYCIN HYDROCHLORIDE | 1 | 0.0003 |
| 9 | EFGARTIGIMOD ALFA | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 4 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 5 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 6 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 7 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 9 | Aluminum Complex [EPC] | 1 | 0.0000 |